INJ Search

CLOSE


Search

  • HOME
  • Search
Clinical Investigation
Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron 50 mg in Sexually Active Men With Bothersome Overactive Bladder Symptoms – A Multicenter, Randomized Study
Chih-Chieh Lin, Hann-Chorng Kuo, Jian-Ri Li, Yao-Chi Chuang
Int Neurourol J. 2023;27(3):182-191.   Published online 2023 September 30
Full textPubreaderePubPDF
inj-2346148-074f1.gifinj-2346148-074f2.gif
Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
Yankai Xu, Ruihua Liu, Chu Liu, Yuanshan Cui, Zhenli Gao
Int Neurourol J. 2017;21(3):212-219.   Published online 2017 September 12
Full textPubreaderePubPDF
inj-1734934-467f1.gifinj-1734934-467f2.gifinj-1734934-467f3.gifinj-1734934-467f4.gifinj-1734934-467f5.gif
1 |

Journal Impact Factor 2.3
E-Submission
  • Regulation on Ethics
  • Best Practice
  • article_btn
  • Copyright transfer form / Conflict of Interest Statement / Author consent for use of PPT
  • Endnote Style File
  • Email Alert
  • Author's Index
  • E-Submission
Related society
Indexed By
Crossref Services
templates
SCImago Journal & Country Rank


ARTICLE & ORGAN
Article Category

Browse all articles >

Organ

Browse all articles >

ISSUES
DISEASES & TOPICS
Diseases

Browse all articles >

Topics

Browse all articles >

AUTHOR
INFORMATION

Official Journal of Korean Continence Society & ESSIC (International Society for the Study of BPS) & Korean Society of Urological Research & The Korean Children’s Continence and Enuresis Society & The Korean Association of Urogenital Tract Infection and Inflammation & Korean Society of Geriatric Urological Care
Editorial Office
Department of Urology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine,
29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea
Tel: +82-2-2001-2237     Fax: +82-2-2001-2247    E-mail: choys1011@naver.com

Copyright © 2024 by Korean Continence Society.

Developed in M2PI

Close layer
prev next